The company has developed SyncAV CRT software algorithm to function independently or in conjunction with MultiPoint Pacing (MPP) technology to treat heart failure patients.
SyncAV technology is said to automatically adjust pacing based on real-time changes in a patient’s cardiac condition. It also enables physicians to treat patients who have responded positively to traditional CRT.
The software also offers physicians with additional options to individually optimize CRT settings for their heart failure patients.
St. Jude Medical chief medical officer and global clinical affairs vice president Dr Mark Carlson said: “St. Jude Medical has a proven dedication to continued leadership in heart failure management to help physicians manage some of their most complex patients.
“Approval of the SyncAV CRT technology is important for those patients who are not getting the desired response from traditional cardiac resynchronization therapy.”
For heart failure patients, the CRT technology resynchronizes the lower chambers (ventricles) of the heart by sending uniquely programmed electrical impulses to stimulate each ventricle to beat in sync to provide improved cardiac performance.
The data of the company’s investigational device exemption (IDE) clinical study for MPP technology demonstrated that it reached its primary endpoints of safety and efficacy.
In 2009, the firm developed its first quadripolar pacing system to treat patients with heart failure. It features four pacing electrodes.
